从EP4对抗性到EP2/EP4双重对抗性的微妙结构变化:一种新的类型的环基衍生物
Zhiyuan Cheng1, Yao Zhang1, Limin Du2
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.
Journal of medicinal chemistry
|January 6, 2025
概括
研究人员开发了用于癌症免疫治疗的新型双质前列腺素E2受体2/4 (EP2/EP4) 抗剂. 化合物29 (CZY-1068) 通过减少巨细胞中的免疫抑制基因,显示出显著的抗瘤疗效.
科学领域:
- 药用化学 医学化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 前列腺素E2受体 (EP2/EP4) 是癌症免疫疗法的关键标.
- 开发双重EP2/EP4抗剂是一种有前途的治疗策略.
研究的目的:
- 发现新型的4,7-二-5H-[2,3-c]衍生物作为强大的EP2/EP4双抗体.
- 为了研究双重对抗的结构-活动关系.
- 在临床前癌症模型中评估已识别的化合物的治疗潜力.
主要方法:
- 合理的药物设计和合成丁诺普兰衍生物.
- 在体外检测EP2/EP4对抗性的试验.
- 分子动力学模拟以了解受体-连接体相互作用.
- 在体内研究使用合成的MC38瘤模型.
主要成果:
- 鉴定出基于诺普兰支架的强效EP2/EP4双抗体.
- 双侧链被确定为双相对抗的关键.
- 化合物29 (CZY-1068) 显示显著减少了免疫抑制基因.
- 化合物29在体内表现出强大的抗瘤疗效.
结论:
- 通过合理的结构修改,成功开发出新型强大的双重EP2/EP4抗剂.
- 化合物29 (CZY-1068) 是癌症免疫治疗的有希望的候选者.
- 这项研究提供了针对癌症治疗中的EP2/EP4受体的概念证明.
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
516
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
516
Acid-Catalyzed Ring-Opening of Epoxides
7.1K
Epoxides that are three-membered ring systems are more reactive than other cyclic and acyclic ethers. The high reactivity of epoxides originates from the strain present in the ring. This ring strain acts as a driving force for epoxides to undergo ring-opening reactions either with halogen acids or weak nucleophiles in the presence of mild acid. The acid catalyst converts the epoxide oxygen, a poor leaving group, into an oxonium ion, a better leaving group, making the reaction feasible. The...
7.1K
ortho–para-Directing Deactivators: Halogens
5.3K
Halogens are ortho–para directors. They are more electronegative than carbon. Therefore, as ring substituents, they can withdraw electrons through the inductive effect and deactivate the aromatic ring towards electrophilic substitution. Halogens also have an electron-donating resonance effect on the ring, which influences the orientation of the incoming electrophile. If an electrophile attacks at the ortho or the para position, the halogen donates electrons and stabilizes the intermediate...
5.3K
Base-Catalyzed Ring-Opening of Epoxides
8.3K
Due to their highly strained structures, epoxides can readily undergo ring-opening reactions through nucleophilic substitution, either in the presence of an acid or a base. The nucleophilic substitution reactions in the presence of acid are called acid-catalyzed ring-opening reactions, and nucleophilic substitution reactions in the presence of a base are called base-catalyzed ring-opening reactions. Epoxides undergo base-catalyzed ring-opening reactions in the presence of a strong nucleophile...
8.3K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K

![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)
